Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2025-12-24 @ 5:54 PM
NCT ID:
NCT05607368
Eligibility Criteria:
Inclusion Criteria:
1. Healthy control group
* Voluntary signing of informed consent;
* Healthy volunteers older than 18 years old and less than 50 years old, regardless of gender;
* No systemic diseases or neurological symptoms or signs;
* According to the judge's judgment, healthy volunteers matching the NPSLE epilepsy group in terms of gender, age, and education level were selected as the control group.
2. SLE group
* Voluntary signing of informed consent;
* Age greater than 18 years old, less than 50 years old, gender is not limited;
* Patients with SLE who meet diagnostic criteria.
3. NPSLE Epilepsy Group
* Voluntary signing of informed consent;
* Age greater than 18 years old, less than 50 years old, gender is not limited;
* Patients with NPSLE epilepsy who meet diagnostic criteria.
Exclusion Criteria:
1. SLE group
* patients with SLE with other autoimmune diseases;
* Previous seizures, psychiatric abnormalities and other manifestations;
* MR of the head has obvious abnormal signals in the skull or EEG shows abnormal signals;
* History of use of hormones and immunosuppressants;
* The investigators judged that it was not suitable to participate in this study.
2. NPSLE Epilepsy Group
* prior history of epilepsy or clear cranial MR findings suggesting structural abnormalities;
* Presence of precipitating seizures such as sleep deprivation, high fever, infection, long-term abstinence from alcoholism
* Interrupt, patients with systemic diseases such as hypoglycemia, severe electrolyte disorders, malignant lesions, progressive or degenerative diseases, severe liver and kidney insufficiency and other metabolic diseases;
* The investigators judged that it was not suitable to participate in this study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT05607368
Study Brief:
Protocol Section:
NCT05607368